We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MATW:NASDAQMatthews International Corporation Analysis

Data as of 2026-08-02 - not real-time

$27.75

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Matthews International (MATW) trades at a price of $27.75, well above its DCF fair value of $13.66 and a trailing P/E of 92.5 versus an industry average of ~31, indicating significant overvaluation. Technical indicators are broadly bullish – the 20‑day SMA (27.33) sits just below the current price, the MACD histogram is positive, and the RSI is neutral at 53, suggesting limited downside pressure in the near term. However, the fundamentals are weak: revenue has contracted by nearly 40%, operating margins are razor‑thin (≈0.6%), and the company is generating negative operating cash flow while carrying a debt‑to‑equity ratio over 120%. The dividend yield of 3.67% looks attractive but the payout ratio exceeds 300%, raising serious sustainability concerns. Recent filings hint at upcoming Q3 results but provide no clear catalyst to justify the current premium.
Investors should weigh the short‑term technical tailwinds against the long‑term structural challenges of declining sales, high leverage, and an unsustainable dividend policy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish short‑term technical setup (price above 20‑day SMA, positive MACD)
  • Severe overvaluation relative to DCF and peers
  • Negative operating cash flow and high leverage

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued revenue decline and marginal operating margins
  • Unsustainable dividend payout exceeding 300%
  • Valuation gap (price >2x DCF fair value) with limited earnings upside

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Structural financial weakness (high debt, low ROE/ROA)
  • Fundamental overvaluation and lack of clear growth catalyst
  • Potential for dividend cuts or suspension, eroding total return

Key Metrics & Analysis

Financial Health

Revenue Growth-39.50%
Profit Margin0.80%
P/E Ratio92.5
ROE2.11%
ROA0.69%
Debt/Equity124.30
P/B Ratio1.7
Op. Cash Flow$-72299000
Free Cash Flow$80.1M
Industry P/E30.9

Technical Analysis

TrendBullish
RSI53.8
Support$25.85
Resistance$29.14
MA 20$27.33
MA 50$26.73
MA 200$26.12
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$13.67
Target Price$38.00
Upside/Downside36.94%
GradeOvervalued
TypeValue
Dividend Yield3.67%

Risk Assessment

Beta0.73
Volatility31.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.